Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) Completed Phase 3 Trials for Infections, Pneumococcal Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT03615482A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)